E.SunH.AkhlaghiF.LeggioL
Relevance to humans remains uncertain
What Happens After Initial Consultation If GLP-1 therapy is appropriate: Baseline labs if not recently completed Medication prescription with clear titration schedule Education on side effect management, protein targets, hydration Follow-up scheduled for 4-6 weeks to assess tolerance and response Ongoing monitoring every 8-12 weeks during active weight loss We coordinate with your primary care physician and manage adjustments to other medications (blood pressure, diabetes medications) as your metabolic health improves
Our Confident Body Program is designed for children and adolescents living with obesity, insulin resistance, prediabetes, PMOS (formerly PCOS), and other metabolic conditions
Also, it has not yet been studied in patients with history of pancreatitis, an issue with other GLP-1 agonists
The bacterial strains are still establishing themselves and have not yet reached the population densities needed to meaningfully shift GLP-1 production
